SpeeDx Pty.
Latest round
- Series B
Last raised
- Feb 2020
Total raised
- $33M
Investors
- 3
About SpeeDx Pty.
SpeeDx Pty. Ltd.Founded in 2009 in Sydney, Australia, SpeeDx Pty. Ltd. specializes in molecular diagnostics.SpeeDx specializes in advanced molecular diagnostics, primarily offering innovative multiplex qPCR assays designed for research purposes. Their core product suite includes assays for detecting sexually transmitted infections (STIs), respiratory infections, and antibiotic resistance markers. Key products, such as the Plex Plus® technology, enable simultaneous detection of multiple targets in a single-well reaction, significantly enhancing laboratory efficiency and output. The company’s products are utilized in various research settings to address unmet needs in infectious disease monitoring, with a customer base that frequently includes clinical laboratories, academic institutions, and research organizations in North America, Europe, and Australia.10 and an EBITDA of USD 13,609,720. The revenue model is based on the sale of Research Use Only (RUO) assays, which are not intended for diagnostic use. The company engages in direct sales to clients, including laboratories and research institutions, through a structured business-to-business (B2B) approach. Transactions typically involve bulk orders of their proprietary multiplex assays, with clients purchasing products such as the RespiV Plex Plus® for respiratory infection research or the Plex Prime® kits for STI detection. The pricing structure is tailored to accommodate various research project sizes, allowing for flexibility in order quantities and facilitating partnerships with larger research initiatives.In February 2023, SpeeDx Pty. Ltd. The company also plans to expand its market presence, specifically targeting Europe and North America by the end of 2024. This strategic growth will allow SpeeDx to reach a broader clientele and improve access to their innovative solutions in molecular diagnostics.
Who invested in SpeeDx Pty.
3 investors across 4 rounds
See all investors in SpeeDx Pty.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about SpeeDx Pty.
Who invested in SpeeDx Pty.?
SpeeDx Pty. has 3 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SpeeDx Pty. raised?
SpeeDx Pty. has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did SpeeDx Pty. last raise money?
SpeeDx Pty.'s most recent round on record is a Series B, in Feb 2020.
What does SpeeDx Pty. do?
SpeeDx Pty. is a healthcare company.
Where is SpeeDx Pty. headquartered?
SpeeDx Pty. is headquartered in Sydney, Australia.
Which VCs invest in companies like SpeeDx Pty.?
Among active investors with capital left to deploy, Brandon Capital Partners, King River Capital, Boman Group and HEAL Partners back healthcare companies at SpeeDx Pty.'s stage. Their profiles are linked below.
VCs backing healthcare startups at Series B
Raising like SpeeDx Pty.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.